Recombinant Hemagglutinin-Influenza A Virus H3N2 Victoria 361/2011 [H3N2 Influenza A]
#
-
Catalog numberMBS146863
-
Price:
-
Size0.1 mg
-
-
Products_typeRecombinant Protein
-
Products_gene_name[H3N2]
-
DescriptionInfluenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.
-
SourceRecombinants or rec. proteins
-
Grouprecombinants
-
Gene target
-
Short nameRecombinant Hemagglutinin-Influenza A Virus H3N2 Victoria 361/2011 [H3N2 Influenza A]
-
TechniqueRecombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. MyBioSource advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
-
HostBaculovirus Insect Cells
-
SpeciesInfluenza, Viruses
-
Alternative nameRec. Hemagglutinin-Influenza A Virus H3N2 Victoria 361/2011 [H3N2 Influenza A]
-
Alternative techniquerec
-
Virusinfluenza
-
MeSH Data
-
Name
-
ConceptScope note: Radioimmunoassay of proteins using antibody coupled to an immunosorbent.
-
Tree numbers
- E05.478.566.380.830
- E05.478.566.639.830
- E05.601.470.380.830
- E05.601.470.639.830
-
Qualifiersethics, mortality, psychology, trends, veterinary, history, classification, economics, instrumentation, methods, nursing, standards, adverse effects, statistics & numerical data